| 000 | 01778 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515065008.0 | ||
| 264 | 0 | _c20070816 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a0899-823X | ||
| 024 | 7 |
_a10.1086/513616 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMéan, M | |
| 245 | 0 | 0 |
_aA neonatal specialist with recurrent methicillin-resistant Staphylococcus aureus (MRSA) carriage implicated in the transmission of MRSA to newborns. _h[electronic resource] |
| 260 |
_bInfection control and hospital epidemiology _cMay 2007 |
||
| 300 |
_a625-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAcademic Medical Centers |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarrier State _xmicrobiology |
| 650 | 0 | 4 |
_aCross Infection _xprevention & control |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 | _aDrug Resistance, Multiple, Bacterial |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInfectious Disease Transmission, Professional-to-Patient _xprevention & control |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMupirocin _xadministration & dosage |
| 650 | 0 | 4 |
_aNasal Mucosa _xmicrobiology |
| 650 | 0 | 4 | _aNeonatology |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xepidemiology |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aUmbilical Cord _xmicrobiology |
| 700 | 1 | _aMallaret, M R | |
| 700 | 1 | _aAndrini, P | |
| 700 | 1 | _aRecule, C | |
| 700 | 1 | _aDebillon, T | |
| 700 | 1 | _aPavese, P | |
| 700 | 1 | _aCroizé, J | |
| 773 | 0 |
_tInfection control and hospital epidemiology _gvol. 28 _gno. 5 _gp. 625-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/513616 _zAvailable from publisher's website |
| 999 |
_c17013253 _d17013253 |
||